Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Asia-Pacific Cervical Forceps Market by Product (Linear, Curved) and by Application (Single-use, Reusable): Global Opportunity Analysis and Industry Forecast, 2023-2032

A03824

Pages: NA

Charts: NA

Tables: NA

Gynecologists use cervical forceps to examine a woman for cervical cancer. Cervical biopsy forceps are also used to delicately manipulate the tissue during surgery by gynecologists instead of using their fingers. They are available in multiple designs to fit various surgical sites and conditions. These forceps are sterile & durable and are manufactured with high-quality steel to withstand the heat and temperatures of sterilization.

The major factors that fuel the growth of the Asia-Pacific cervical forceps market include increase in the prevalence of cervical cancers, rise in the number of cervical cancer surgical procedures, growing demand for minimally invasive procedures, rise in death rate due to cervical cancer, and growth in obese population. However, ineffective healthcare infrastructure, low awareness among people towards these devices, and stringent government regulations related to the manufacture & sales of the devices are anticipated to restrain the growth of this market. Moreover, rise in cancer awareness programs will drive the market growth.

The Asia-Pacific cervical forceps market is segmented on the basis of product, application, and country. Based on product, the market is bifurcated into linear and curved. Applications covered in the study include single-use and reusable forceps. By country, this market has been analyzed across Japan, China, India, Australia, South Korea, and Rest of Asia-Pacific.

The key players that operate in the market include Teleflex Incorporated, Pelican Feminine Healthcare, CareFusion Corporation, GPC Medical Ltd., Medline Industries, Inc., Sklar Surgical Instruments, AliMed, Integra LifeSciences Corporation, Black Smith Surgical, and N.S Surgical.

Key Benefits

  • The study provides an in-depth analysis of the Asia-Pacific cervical forceps market with current trends and future estimations to elucidate imminent investment pockets.
  • The report provides information about the current and upcoming trends in the Asia-Pacific cervical forceps market from 2016 to 2023, which helps determine prevailing opportunities.
  • Comprehensive analysis of factors that drive and restrict the growth of the Asia-Pacific cervical forceps market has been provided.
  • Identification of factors that are instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a regional scale have been provided.
  • Key market players within the market have been profiled in this report and their strategies thoroughly analyzed, which help understand the competitive outlook of the Asia-Pacific cervical forceps market.

Asia-pacific Cervical Forceps Market Key Segments:

By Product

  • Linear
  • Curved

By Application

  • Single-use
  • Reusable

By Country

  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific

Key Market Segments

  • By Product
    • Linear
    • Curved
  • By Application
    • Single-use
    • Reusable
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA


Key Market Players

  • GPC Medical Ltd.
  • Black Smith Surgical
  • N.S Surgical.
  • AliMed
  • CareFusion Corporation
  • Integra LifeSciences Corporation
  • Teleflex Incorporated
  • Sklar Surgical Instruments
  • Pelican Feminine Healthcare
  • Medline Industries, Inc.
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: ASIA-PACIFIC CERVICAL FORCEPS MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Linear

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Curved

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: ASIA-PACIFIC CERVICAL FORCEPS MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Single-use

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Reusable

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

  • CHAPTER 6: ASIA-PACIFIC CERVICAL FORCEPS MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Product

      • 6.2.3. Market Size and Forecast, By Application

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S.

        • 6.2.5.1 Market size and forecast, product

        • 6.2.5.2 Market size and forecast, application

      • 6.2.6. Canada

        • 6.2.6.1 Market size and forecast, product

        • 6.2.6.2 Market size and forecast, application

      • 6.2.7. Mexico

        • 6.2.7.1 Market size and forecast, product

        • 6.2.7.2 Market size and forecast, application

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Product

      • 6.3.3. Market Size and Forecast, By Application

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France

        • 6.3.5.1 Market size and forecast, product

        • 6.3.5.2 Market size and forecast, application

      • 6.3.6. Germany

        • 6.3.6.1 Market size and forecast, product

        • 6.3.6.2 Market size and forecast, application

      • 6.3.7. Italy

        • 6.3.7.1 Market size and forecast, product

        • 6.3.7.2 Market size and forecast, application

      • 6.3.8. Spain

        • 6.3.8.1 Market size and forecast, product

        • 6.3.8.2 Market size and forecast, application

      • 6.3.9. UK

        • 6.3.9.1 Market size and forecast, product

        • 6.3.9.2 Market size and forecast, application

      • 6.3.10. Russia

        • 6.3.10.1 Market size and forecast, product

        • 6.3.10.2 Market size and forecast, application

      • 6.3.11. Rest Of Europe

        • 6.3.11.1 Market size and forecast, product

        • 6.3.11.2 Market size and forecast, application

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Product

      • 6.4.3. Market Size and Forecast, By Application

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China

        • 6.4.5.1 Market size and forecast, product

        • 6.4.5.2 Market size and forecast, application

      • 6.4.6. Japan

        • 6.4.6.1 Market size and forecast, product

        • 6.4.6.2 Market size and forecast, application

      • 6.4.7. India

        • 6.4.7.1 Market size and forecast, product

        • 6.4.7.2 Market size and forecast, application

      • 6.4.8. South Korea

        • 6.4.8.1 Market size and forecast, product

        • 6.4.8.2 Market size and forecast, application

      • 6.4.9. Australia

        • 6.4.9.1 Market size and forecast, product

        • 6.4.9.2 Market size and forecast, application

      • 6.4.10. Thailand

        • 6.4.10.1 Market size and forecast, product

        • 6.4.10.2 Market size and forecast, application

      • 6.4.11. Malaysia

        • 6.4.11.1 Market size and forecast, product

        • 6.4.11.2 Market size and forecast, application

      • 6.4.12. Indonesia

        • 6.4.12.1 Market size and forecast, product

        • 6.4.12.2 Market size and forecast, application

      • 6.4.13. Rest of Asia Pacific

        • 6.4.13.1 Market size and forecast, product

        • 6.4.13.2 Market size and forecast, application

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Product

      • 6.5.3. Market Size and Forecast, By Application

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil

        • 6.5.5.1 Market size and forecast, product

        • 6.5.5.2 Market size and forecast, application

      • 6.5.6. South Africa

        • 6.5.6.1 Market size and forecast, product

        • 6.5.6.2 Market size and forecast, application

      • 6.5.7. Saudi Arabia

        • 6.5.7.1 Market size and forecast, product

        • 6.5.7.2 Market size and forecast, application

      • 6.5.8. UAE

        • 6.5.8.1 Market size and forecast, product

        • 6.5.8.2 Market size and forecast, application

      • 6.5.9. Argentina

        • 6.5.9.1 Market size and forecast, product

        • 6.5.9.2 Market size and forecast, application

      • 6.5.10. Rest of LAMEA

        • 6.5.10.1 Market size and forecast, product

        • 6.5.10.2 Market size and forecast, application

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning,2022

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Teleflex Incorporated

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Pelican Feminine Healthcare

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. CareFusion Corporation

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. GPC Medical Ltd.

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Medline Industries, Inc.

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Sklar Surgical Instruments

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. AliMed

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Integra LifeSciences Corporation

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Black Smith Surgical

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. N.S Surgical.

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL ASIA-PACIFIC CERVICAL FORCEPS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 2. ASIA-PACIFIC CERVICAL FORCEPS MARKET FOR LINEAR, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. ASIA-PACIFIC CERVICAL FORCEPS MARKET FOR CURVED, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL ASIA-PACIFIC CERVICAL FORCEPS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 5. ASIA-PACIFIC CERVICAL FORCEPS MARKET FOR SINGLE-USE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. ASIA-PACIFIC CERVICAL FORCEPS MARKET FOR REUSABLE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. ASIA-PACIFIC CERVICAL FORCEPS MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. NORTH AMERICA ASIA-PACIFIC CERVICAL FORCEPS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 9. NORTH AMERICA ASIA-PACIFIC CERVICAL FORCEPS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 10. NORTH AMERICA ASIA-PACIFIC CERVICAL FORCEPS, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 11. U.S. ASIA-PACIFIC CERVICAL FORCEPS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 12. U.S. ASIA-PACIFIC CERVICAL FORCEPS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 13. CANADA ASIA-PACIFIC CERVICAL FORCEPS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 14. CANADA ASIA-PACIFIC CERVICAL FORCEPS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 15. MEXICO ASIA-PACIFIC CERVICAL FORCEPS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 16. MEXICO ASIA-PACIFIC CERVICAL FORCEPS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 17. EUROPE ASIA-PACIFIC CERVICAL FORCEPS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 18. EUROPE ASIA-PACIFIC CERVICAL FORCEPS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 19. EUROPE ASIA-PACIFIC CERVICAL FORCEPS, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 20. FRANCE ASIA-PACIFIC CERVICAL FORCEPS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 21. FRANCE ASIA-PACIFIC CERVICAL FORCEPS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 22. GERMANY ASIA-PACIFIC CERVICAL FORCEPS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 23. GERMANY ASIA-PACIFIC CERVICAL FORCEPS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 24. ITALY ASIA-PACIFIC CERVICAL FORCEPS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 25. ITALY ASIA-PACIFIC CERVICAL FORCEPS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 26. SPAIN ASIA-PACIFIC CERVICAL FORCEPS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 27. SPAIN ASIA-PACIFIC CERVICAL FORCEPS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 28. UK ASIA-PACIFIC CERVICAL FORCEPS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 29. UK ASIA-PACIFIC CERVICAL FORCEPS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 30. RUSSIA ASIA-PACIFIC CERVICAL FORCEPS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 31. RUSSIA ASIA-PACIFIC CERVICAL FORCEPS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 32. REST OF EUROPE ASIA-PACIFIC CERVICAL FORCEPS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 33. REST OF EUROPE ASIA-PACIFIC CERVICAL FORCEPS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 34. ASIA-PACIFIC ASIA-PACIFIC CERVICAL FORCEPS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 35. ASIA-PACIFIC ASIA-PACIFIC CERVICAL FORCEPS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 36. ASIA-PACIFIC ASIA-PACIFIC CERVICAL FORCEPS, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 37. CHINA ASIA-PACIFIC CERVICAL FORCEPS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 38. CHINA ASIA-PACIFIC CERVICAL FORCEPS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 39. JAPAN ASIA-PACIFIC CERVICAL FORCEPS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 40. JAPAN ASIA-PACIFIC CERVICAL FORCEPS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 41. INDIA ASIA-PACIFIC CERVICAL FORCEPS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 42. INDIA ASIA-PACIFIC CERVICAL FORCEPS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 43. SOUTH KOREA ASIA-PACIFIC CERVICAL FORCEPS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 44. SOUTH KOREA ASIA-PACIFIC CERVICAL FORCEPS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 45. AUSTRALIA ASIA-PACIFIC CERVICAL FORCEPS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 46. AUSTRALIA ASIA-PACIFIC CERVICAL FORCEPS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 47. THAILAND ASIA-PACIFIC CERVICAL FORCEPS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 48. THAILAND ASIA-PACIFIC CERVICAL FORCEPS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 49. MALAYSIA ASIA-PACIFIC CERVICAL FORCEPS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 50. MALAYSIA ASIA-PACIFIC CERVICAL FORCEPS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 51. INDONESIA ASIA-PACIFIC CERVICAL FORCEPS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 52. INDONESIA ASIA-PACIFIC CERVICAL FORCEPS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 53. REST OF ASIA PACIFIC ASIA-PACIFIC CERVICAL FORCEPS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 54. REST OF ASIA PACIFIC ASIA-PACIFIC CERVICAL FORCEPS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 55. LAMEA ASIA-PACIFIC CERVICAL FORCEPS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 56. LAMEA ASIA-PACIFIC CERVICAL FORCEPS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 57. LAMEA ASIA-PACIFIC CERVICAL FORCEPS, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 58. BRAZIL ASIA-PACIFIC CERVICAL FORCEPS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 59. BRAZIL ASIA-PACIFIC CERVICAL FORCEPS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 60. SOUTH AFRICA ASIA-PACIFIC CERVICAL FORCEPS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 61. SOUTH AFRICA ASIA-PACIFIC CERVICAL FORCEPS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 62. SAUDI ARABIA ASIA-PACIFIC CERVICAL FORCEPS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 63. SAUDI ARABIA ASIA-PACIFIC CERVICAL FORCEPS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 64. UAE ASIA-PACIFIC CERVICAL FORCEPS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 65. UAE ASIA-PACIFIC CERVICAL FORCEPS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 66. ARGENTINA ASIA-PACIFIC CERVICAL FORCEPS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 67. ARGENTINA ASIA-PACIFIC CERVICAL FORCEPS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 68. REST OF LAMEA ASIA-PACIFIC CERVICAL FORCEPS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 69. REST OF LAMEA ASIA-PACIFIC CERVICAL FORCEPS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 70. TELEFLEX INCORPORATED: KEY EXECUTIVES
  • TABLE 71. TELEFLEX INCORPORATED: COMPANY SNAPSHOT
  • TABLE 72. TELEFLEX INCORPORATED: OPERATING SEGMENTS
  • TABLE 73. TELEFLEX INCORPORATED: PRODUCT PORTFOLIO
  • TABLE 74. TELEFLEX INCORPORATED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 75. PELICAN FEMININE HEALTHCARE: KEY EXECUTIVES
  • TABLE 76. PELICAN FEMININE HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 77. PELICAN FEMININE HEALTHCARE: OPERATING SEGMENTS
  • TABLE 78. PELICAN FEMININE HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 79. PELICAN FEMININE HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 80. CAREFUSION CORPORATION: KEY EXECUTIVES
  • TABLE 81. CAREFUSION CORPORATION: COMPANY SNAPSHOT
  • TABLE 82. CAREFUSION CORPORATION: OPERATING SEGMENTS
  • TABLE 83. CAREFUSION CORPORATION: PRODUCT PORTFOLIO
  • TABLE 84. CAREFUSION CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 85. GPC MEDICAL LTD.: KEY EXECUTIVES
  • TABLE 86. GPC MEDICAL LTD.: COMPANY SNAPSHOT
  • TABLE 87. GPC MEDICAL LTD.: OPERATING SEGMENTS
  • TABLE 88. GPC MEDICAL LTD.: PRODUCT PORTFOLIO
  • TABLE 89. GPC MEDICAL LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 90. MEDLINE INDUSTRIES, INC.: KEY EXECUTIVES
  • TABLE 91. MEDLINE INDUSTRIES, INC.: COMPANY SNAPSHOT
  • TABLE 92. MEDLINE INDUSTRIES, INC.: OPERATING SEGMENTS
  • TABLE 93. MEDLINE INDUSTRIES, INC.: PRODUCT PORTFOLIO
  • TABLE 94. MEDLINE INDUSTRIES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 95. SKLAR SURGICAL INSTRUMENTS: KEY EXECUTIVES
  • TABLE 96. SKLAR SURGICAL INSTRUMENTS: COMPANY SNAPSHOT
  • TABLE 97. SKLAR SURGICAL INSTRUMENTS: OPERATING SEGMENTS
  • TABLE 98. SKLAR SURGICAL INSTRUMENTS: PRODUCT PORTFOLIO
  • TABLE 99. SKLAR SURGICAL INSTRUMENTS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 100. ALIMED: KEY EXECUTIVES
  • TABLE 101. ALIMED: COMPANY SNAPSHOT
  • TABLE 102. ALIMED: OPERATING SEGMENTS
  • TABLE 103. ALIMED: PRODUCT PORTFOLIO
  • TABLE 104. ALIMED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 105. INTEGRA LIFESCIENCES CORPORATION: KEY EXECUTIVES
  • TABLE 106. INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
  • TABLE 107. INTEGRA LIFESCIENCES CORPORATION: OPERATING SEGMENTS
  • TABLE 108. INTEGRA LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO
  • TABLE 109. INTEGRA LIFESCIENCES CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 110. BLACK SMITH SURGICAL: KEY EXECUTIVES
  • TABLE 111. BLACK SMITH SURGICAL: COMPANY SNAPSHOT
  • TABLE 112. BLACK SMITH SURGICAL: OPERATING SEGMENTS
  • TABLE 113. BLACK SMITH SURGICAL: PRODUCT PORTFOLIO
  • TABLE 114. BLACK SMITH SURGICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 115. N.S SURGICAL.: KEY EXECUTIVES
  • TABLE 116. N.S SURGICAL.: COMPANY SNAPSHOT
  • TABLE 117. N.S SURGICAL.: OPERATING SEGMENTS
  • TABLE 118. N.S SURGICAL.: PRODUCT PORTFOLIO
  • TABLE 119. N.S SURGICAL.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL ASIA-PACIFIC CERVICAL FORCEPS MARKET SEGMENTATION
  • FIGURE 2. GLOBAL ASIA-PACIFIC CERVICAL FORCEPS MARKET
  • FIGURE 3. SEGMENTATION ASIA-PACIFIC CERVICAL FORCEPS MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN ASIA-PACIFIC CERVICAL FORCEPS MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALASIA-PACIFIC CERVICAL FORCEPS MARKET
  • FIGURE 11. ASIA-PACIFIC CERVICAL FORCEPS MARKET SEGMENTATION, BY PRODUCT
  • FIGURE 12. ASIA-PACIFIC CERVICAL FORCEPS MARKET FOR LINEAR, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. ASIA-PACIFIC CERVICAL FORCEPS MARKET FOR CURVED, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. ASIA-PACIFIC CERVICAL FORCEPS MARKET SEGMENTATION, BY APPLICATION
  • FIGURE 15. ASIA-PACIFIC CERVICAL FORCEPS MARKET FOR SINGLE-USE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. ASIA-PACIFIC CERVICAL FORCEPS MARKET FOR REUSABLE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 18. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 19. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 20. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 21. COMPETITIVE DASHBOARD
  • FIGURE 22. COMPETITIVE HEATMAP: ASIA-PACIFIC CERVICAL FORCEPS MARKET
  • FIGURE 23. TOP PLAYER POSITIONING,2022
  • FIGURE 24. TELEFLEX INCORPORATED: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 25. TELEFLEX INCORPORATED: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 26. TELEFLEX INCORPORATED: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 27. PELICAN FEMININE HEALTHCARE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 28. PELICAN FEMININE HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 29. PELICAN FEMININE HEALTHCARE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 30. CAREFUSION CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 31. CAREFUSION CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 32. CAREFUSION CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 33. GPC MEDICAL LTD.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 34. GPC MEDICAL LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 35. GPC MEDICAL LTD.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 36. MEDLINE INDUSTRIES, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 37. MEDLINE INDUSTRIES, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 38. MEDLINE INDUSTRIES, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 39. SKLAR SURGICAL INSTRUMENTS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 40. SKLAR SURGICAL INSTRUMENTS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 41. SKLAR SURGICAL INSTRUMENTS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 42. ALIMED: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 43. ALIMED: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 44. ALIMED: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 45. INTEGRA LIFESCIENCES CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 46. INTEGRA LIFESCIENCES CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 47. INTEGRA LIFESCIENCES CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 48. BLACK SMITH SURGICAL: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. BLACK SMITH SURGICAL: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 50. BLACK SMITH SURGICAL: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 51. N.S SURGICAL.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 52. N.S SURGICAL.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 53. N.S SURGICAL.: REVENUE SHARE, BY REGION, 2032 (%)

Purchase Full Report of
Asia-Pacific Cervical Forceps Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue